Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bupropion in the Treatment of Pathological Gambling

This study has been completed.
Sponsor:
Collaborator:
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
Donald Black, University of Iowa
ClinicalTrials.gov Identifier:
NCT00055393
First received: February 28, 2003
Last updated: May 14, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2006
  Primary Completion Date: May 2005 (Final data collection date for primary outcome measure)